Google TrendPANTHERS VS BLUE JACKETS (200+) — Gameday 7: Florida Panthers at Columbus Blue Jackets
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Non-Diabetic Patients on" (30 stories)

Top Headline Story

Comparison of ocular biometrics between diabetic and non-diabetic adults: a population-based study
Lead StoryNaturegeneral
Jun 8

Comparison of ocular biometrics between diabetic and non-diabetic adults: a population-based study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBVTHZmQ2NVbUJiVi1GR01IQTBpcVp0TVE2b3VEb3VuWHhqM3FHVFRsamt0Z2g3MEpnNFBMbzZSMG53TUtGTzNNQUFRVzNEUFpIM1dodFJ3NVlDbnNiUnVV?oc=5" target="_blank">Comparison of ocular biometrics between diabetic and non-diabetic adults: a population-based study</a>  <font color="#6f6f6f">Nature</font>

Real-time search volume
200+17m ago

panthers vs blue jackets

Gameday 7: Florida Panthers at Columbus Blue Jackets

5000+27m ago

posiciones de atlético de madrid contra manchester united

Atlético 2 - 0 Manchester United: resumen, goles y resultado de la Champions League

2000+27m ago

devils vs red wings

Devils at Red Wings projected lineups

5000+27m ago

lioness season 3

Thank Zoe Saldaña for ‘Lioness’ Season 3’s Perfect Cliff-Hanger

Search Results for "Non-Diabetic Patients on"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Case Report: Euglycemic ketoacidosis in a non-diabetic patient: a rare adverse effect of SGLT2 inhibitor therapy
Frontiersgeneral

Case Report: Euglycemic ketoacidosis in a non-diabetic patient: a rare adverse effect of SGLT2 inhibitor therapy

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQVmlncWV2ZzlEUjlQcEN6a2lqWjdPczF3akFTUTZ3aE5hVzYtRzRNcVFMajBzYjZzYl9jNzhWMUtnUGxhUEpfWWd5RUVZZE56X3FNRlJYMXZYcmFvd0laZUJYa2h2WEE4aUM5NkxQa1ZuZkEtWWMwc2lTTGhiRm80RGgxS1p3NlBMWnhBYjNEX2dkWW9SMGc?oc=5" target="_blank">Case Report: Euglycemic ketoacidosis in a non-diabetic patient: a rare adverse effect of SGLT2 inhibitor therapy</a>  <font color="#6f6f6f">Frontiers</font>

Are Glucose Monitors Useful for People Who Don’t Have Diabetes?
Johns Hopkins Bloomberg School of Public Healthgeneral

Are Glucose Monitors Useful for People Who Don’t Have Diabetes?

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxQd3lpS2txY3N2MU9QUjlmZ0RHLXZkLXZ3WDhyU0hOSWpPMzYtMGNRd2NmOGZWOGFtRDJ5WHFEY0ZXMFVuNEw1OGZvNUdSbE9GWHpNSTdwX1U2MEVIV0tDdkxONVdGbk95ZGd0aWJXeFk4V0swZE5mLThRQTJvbVBmN1BQc2huTUU?oc=5" target="_blank">Are Glucose Monitors Useful for People Who Don’t Have Diabetes?</a>  <font color="#6f6f6f">Johns Hopkins Bloomberg School of Public Health</font>

A Case for SGLT2 Inhibitors in Non-Diabetic CKD: Sandra Chaparro, MD
AJMCgeneral

A Case for SGLT2 Inhibitors in Non-Diabetic CKD: Sandra Chaparro, MD

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNTHFOa05xQ05zLVdBRy1wUzhSNDRJMXNFUi05TFJpUzNfRGVLUlh0MmFqQy1GVk1hXzdUNkZvSG1mWjBmdjBDZ1IxMGxkVEw1UDR6XzhSX2hEWngzVEItVTRrUC0tcThtNERRODVjd2FMY1FjNjZIUzV6TEZjWTE5UF9OcWFvdEdVbHV3ZkQ3Wkt4akRYakgw?oc=5" target="_blank">A Case for SGLT2 Inhibitors in Non-Diabetic CKD: Sandra Chaparro, MD</a>  <font color="#6f6f6f">AJMC</font>

Finerenone in Persons with Chronic Kidney Disease without Diabetes
NEJMgeneral

Finerenone in Persons with Chronic Kidney Disease without Diabetes

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE1saXlfYlZPYWVpZV9mVWRwV05uam5ReEdYb21YbFVqazl4VDg3NWl1OFJnYmVLV2ZkMUxSS3I4QVNwUXJtYW1LVndEY2hSbjUzVUt6dkF4Q2x1bmVicExWdA?oc=5" target="_blank">Finerenone in Persons with Chronic Kidney Disease without Diabetes</a>  <font color="#6f6f6f">NEJM</font>

GLP-1s Are Associated With Reduced Asthma Exacerbation Risk in Nondiabetic Patients With Obesity
Pharmacy Timesgeneral

GLP-1s Are Associated With Reduced Asthma Exacerbation Risk in Nondiabetic Patients With Obesity

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxQT0NoNFRtV1h0MmtlNmJPeGFQc3pRQW9XSllkTmswSDRwcjVIa2pPVE4wR3lsektiWkstRTJPUE9Vd25CQVJfa0F6cjVlcEE4ekotcWNiUVNUZTE2dUt0Q1hiX0VEMktrWmMxQnp1eWY5Mnd3Tm9ORkVIb1pzRnp2MG1waThqRWhqUEJ0LWRDWVRIRDU0N3ZUZlRjREhiR1FUQkR0Z1VrSXNqRlp6M2VqZ3Q5MGFfQzFBUU1DY19vMG5abGhjQ3c?oc=5" target="_blank">GLP-1s Are Associated With Reduced Asthma Exacerbation Risk in Nondiabetic Patients With Obesity</a>  <font color="#6f6f6f">Pharmacy Times</font>

Real-World Experience With Dapagliflozin in Non-diabetic Chronic Kidney Disease: A Case Series From India
Cureusworld

Real-World Experience With Dapagliflozin in Non-diabetic Chronic Kidney Disease: A Case Series From India

<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxOaXgweFd1bXp3bUp6ZFFOVmRHZ2RnRDdNZGtDZkhhak4xd3VmeUVmcWJ6a1NJa0Z4c2lmTTZybk5RNkhQWVJOWHg4RkQ5V0I2b1plaTdUa3lfOWRNeFFiYzBqYzd3TWhacGVqOENDX1JtNWNYa1hRVGJ5ODhLT2x5c1I4Zi1vWTZMbTVXQXdHV0NnbzlxSng0WlNyTEZHdHplN2tFa1BVV2h0MUZkeXlrTEQ4amNwbWpxQWs4Rm1CX2s3UHRhbXhDODdzQTBwVkhfNGtJVzdfOTVZVzA?oc=5" target="_blank">Real-World Experience With Dapagliflozin in Non-diabetic Chronic Kidney Disease: A Case Series From India</a>  <font color="#6f6f6f">Cureus</font>

Toxicology Rounds : Emergency Medicine News
Ovidworld

Toxicology Rounds : Emergency Medicine News

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxQZUdFWmhFSW8tYi0weTVVc2hDaWxHZnY0YXdpcjdkcWppZjBjWVBjWWVpdV9qR0Vqb3lpMEVlUGgzWWd1WW9LTGpsb3R5MEl3ZkZQV1hNdXMzNk1OZ0xDMEJyX09OR2JndnkzRW9Dc1FsVmlIYWJ2V3pxTG9nV3dCblVIbVpRNnNTS1d2bG9BNnhUNzdTWTd3N3ktNmJKYTFKdzZ4Szc5QUF6bGxwZWloQnVPb2pSeXdfa21FTTF2STFRSlktSXAyaU5zc3ZqdWVu?oc=5" target="_blank">Toxicology Rounds : Emergency Medicine News</a>  <font color="#6f6f6f">Ovid</font>

Finerenone slows kidney function decline in non-diabetic patients
News-Medicalworld

Finerenone slows kidney function decline in non-diabetic patients

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxQaEx5YXJHVlVRZG00TzZHckxWTVhtUFZGRmRBaTJ0aF9zd2JuNFFURmVTS1gtaFI0TTZNT2g3enZlX2V3bDU3RUZTcDZBdEZZN2JzSWx2VG80dEY2WWJ6V1pzVGZNRV9TM2lHWVg5ZkNfeGdoV0p3M0hZQXNydUlYTzE5OXFxX1Zvb3JJTWljR2d4UGg0VkRpSVV4YlNBenZHSHJWbFl1WEs1Smo3azNyV2U2aw?oc=5" target="_blank">Finerenone slows kidney function decline in non-diabetic patients</a>  <font color="#6f6f6f">News-Medical</font>

Bayer eyes label expansion on Phase III non-diabetic CKD win
Clinical Trials Arenageneral

Bayer eyes label expansion on Phase III non-diabetic CKD win

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQbk5BcUQyRkN2UGpUb2psWkxIUFdHZFEyWkRQOUFwV0wtSDR3ajJzRUVNdHA3QUJ6T09FdVEzSUE2RHpkNVFUMkV0X2JZQm4ySE9VT0hqMXRudlpVaVZKdy00endsZERTUGZXM2tkSmZLbkIyVllqN1k1c0pGOW9nWVplZDA5MEZPTXZYOGtlaE1fd09xdFNubkdwOWRobUU?oc=5" target="_blank">Bayer eyes label expansion on Phase III non-diabetic CKD win</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

GLP-1 Meds Reduce Risk of Various Ocular Complications in Non-diabetic Patients
Review of Optometrygeneral

GLP-1 Meds Reduce Risk of Various Ocular Complications in Non-diabetic Patients

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQSXdBZnhBVkpveXhiRnJBWmNVQ3VlaF80YnpWY29pdUtqQk9DMXFjNTNJRVduOW5BTmlIanhfT0pqcmU1aXNEdS1fNGQ3bVNoamZRbHc4YVllcEpXNVNab3BSM3hYdjF6UE9LVlU3UlR6b0RsS3U0b2dmZzZ2OVkxVlpxdUI5cG02UXBSX3FOcE5hUmtXQUtDWkNRMlViTXlhMXR5R09rOHhNWmV0c3RnUmtxVEJHU0JIZi1B?oc=5" target="_blank">GLP-1 Meds Reduce Risk of Various Ocular Complications in Non-diabetic Patients</a>  <font color="#6f6f6f">Review of Optometry</font>

weight loss drug for non diabetics
www.polskieradio.plgeneral

weight loss drug for non diabetics

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNSU1UX3I5aUZyV0NEWlpMZjE2dUQ3SzB1SDBwYXFUR2NaVU1xSXExMFRoQVRXbU9nMTlZVkZMZ0tsazBaSURHbTlnVnk0YkwxWUY4czU2TlpmRFo0U00xLXlqenJvXzJMRDF0UWtFN2JaTVBNTEdNMnQyaFNjaXN4eDNnTWZZRlRRQ2p2MnV3?oc=5" target="_blank">weight loss drug for non diabetics</a>  <font color="#6f6f6f">www.polskieradio.pl</font>

Preoperative Gastric Ultrasonography in Diabetic Versus Non-diabetic Patients Undergoing Elective Surgery: A Prospective Comparative Observational Study of Gastric Volume and Airway Management Implications
The Cureus Journal of Medical Sciencetech

Preoperative Gastric Ultrasonography in Diabetic Versus Non-diabetic Patients Undergoing Elective Surgery: A Prospective Comparative Observational Study of Gastric Volume and Airway Management Implications

<a href="https://news.google.com/rss/articles/CBMi4AJBVV95cUxQX1NSWmxHMzhuNjV0QW5fVnFXZFh6cUQtcGNRZ2xOOU54Q0dyLTkyNmZkOVJkQVhvYXFOd1N4bjNJUURrejJWRVZpMlJsck56NjJ6Z3RGSWt6X1dZT0IwcXcxUGhUa2lmWEZLdUlWSVdjNnZaeWgwM0t2WnhWcktlRE0wVU9ZTWtlaHR6M0pncER4T0NMWjJkdi0wVkp0OUxack1nMlBBbER0bk5pem1ZdGhFOFNfR2Q0UDlmeU5nV3pPTndFSnNqeUFid2gycEVGSjlYUVJvdC1ST0NFMHg0eDlEUUxBMURMNGpKMGdlZm1SMGRJOUdQU0t2bnJTSGFZdzBSSWNaUzBLVEcyYXpUaUdxTmZta1hja0l3NUdXX0FvSFdWeXNNX0lIa0dadTNhZUEwZzhtdThkSGhxaXJCeWtrel9LWUROZkxzbXlEYkNQVnJwakRnWmVHeVRLZFpM?oc=5" target="_blank">Preoperative Gastric Ultrasonography in Diabetic Versus Non-diabetic Patients Undergoing Elective Surgery: A Prospective Comparative Observational Study of Gastric Volume and Airway Management Implications</a>  <font color="#6f6f6f">The Cureus Journal of Medical Science</font>

Relationship of HOMA-IR with chronic kidney disease in diabetic and non-diabetic Chinese populations: findings from the REACTION study
Frontiersgeneral

Relationship of HOMA-IR with chronic kidney disease in diabetic and non-diabetic Chinese populations: findings from the REACTION study

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQdTlaeFAtZElNVFJrU0xMR3BoR05EZ01XWDBTNG5rZk1LUGZDRC1hc09yWnp5M0hGQmRMallLUkg4cmZ2cV9RZHdnZ05FZ2VFTHdKc29IWVA3N3BpYUtvZDQ4ekg0XzFZQUQyVlRiZy1jV2RNTWh1OHJfRXlvTExhU2RKQWQ4djRiQ3l4eUlUN29DZmRDSVE?oc=5" target="_blank">Relationship of HOMA-IR with chronic kidney disease in diabetic and non-diabetic Chinese populations: findings from the REACTION study</a>  <font color="#6f6f6f">Frontiers</font>

Proteomic analysis identifies distinct signaling pathways in lumbar intervertebral disc degeneration between type-2 diabetic and non-diabetic patients
Naturegeneral

Proteomic analysis identifies distinct signaling pathways in lumbar intervertebral disc degeneration between type-2 diabetic and non-diabetic patients

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA0VmUxYlZIZXRFX0FPdEVtMUFrN1BxeTRzWGx3TEdqR0hiY1ZnV3hOTXJSeExveUQ4OFBPOV80RkZKVzlraGdMTWpyLVFUbkZYbm5ua2dTMmRqOE9LVWR3?oc=5" target="_blank">Proteomic analysis identifies distinct signaling pathways in lumbar intervertebral disc degeneration between type-2 diabetic and non-diabetic patients</a>  <font color="#6f6f6f">Nature</font>

Tirzepatide and Cardiometabolic Effects in Obese Non-diabetic Adults: A Systematic Review, Meta-Analysis, and Narrative Synthesis of Cardiovascular Outcomes
Cureusgeneral

Tirzepatide and Cardiometabolic Effects in Obese Non-diabetic Adults: A Systematic Review, Meta-Analysis, and Narrative Synthesis of Cardiovascular Outcomes

<a href="https://news.google.com/rss/articles/CBMinAJBVV95cUxNWTRlMmN4Y3hhWVVlUmZ0ZnhMS3pEQ3JjaUxZb1phSDZhU1A1ZUtqLW5jdjVUNUktUUdRel9EcjhaQzRDa2V2aVE3TDNKVWJIWGlWWWE2Z1BKb0dTaWJ3MVo5N3RNOThVRDNwWUhRLXZVTXVJM2MtSjdIVkhZLW9ZUmQ4dl9DdTBYOFZhN3d0QkViUFQzUjFtQnNEeXZQYXJOSkpBRnVnMHpVLXVoSUJ1NHF0Q3ZCdGVyQmU2Umc3aHpQSGxFQVlyR1dZd1V0Y0VQRjB5cGI1eEIyTDFBS3BuQkZ6Y0xNa0RQT2pLaDdKWHNENmZzVk0ydlN1dGFNT2x4dkY4Y0JOUFl1VkRwZVg1WXN1VFJGY1dQZzd0Xw?oc=5" target="_blank">Tirzepatide and Cardiometabolic Effects in Obese Non-diabetic Adults: A Systematic Review, Meta-Analysis, and Narrative Synthesis of Cardiovascular Outcomes</a>  <font color="#6f6f6f">Cureus</font>

Visual Outcomes and Complication Profiles of Phacoemulsification in Diabetic Versus Non-diabetic Patients
The Cureus Journal of Medical Sciencegeneral

Visual Outcomes and Complication Profiles of Phacoemulsification in Diabetic Versus Non-diabetic Patients

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxOX3VKWlNBSXNCUFBMbjFhUXVmMl8yVElrdHQzQUZqeEtEUE9BbE54RVNNMVZiS0llLXJ5Umd4VGxIcnZWdUxqVWtoV3B3UXpmZHVscXk1R3dDWVNCLWJ3RE5fa0p5N3lxdUdEVkF5TW5RNVVyTFQ2UjlPWmljMUdMSlBrQWpjVlpQanFTNTNyRk9CWklaU3g0aGJ3V0QwaFFycXBNN1p6MXhUZGVKSEtUMEtRS25WWmNndHVYWU9vRnpvRFhLNU00aVgyZUdUOFdxb1FwLUlLSVdkVHhO?oc=5" target="_blank">Visual Outcomes and Complication Profiles of Phacoemulsification in Diabetic Versus Non-diabetic Patients</a>  <font color="#6f6f6f">The Cureus Journal of Medical Science</font>

Association of Oxidative Stress With Biochemical Markers in Diabetic and Non-diabetic Chronic Kidney Disease Patients: A Cross-Sectional Study
Cureusgeneral

Association of Oxidative Stress With Biochemical Markers in Diabetic and Non-diabetic Chronic Kidney Disease Patients: A Cross-Sectional Study

<a href="https://news.google.com/rss/articles/CBMijAJBVV95cUxONUoxWTVYT3B4WmxfUS1IU2U4akdaU3dfTmpHSnFhX2d2NDRIaTdIdktrcjRuNWZQS3dhd0hVNWxkN1l6VElDQVZrYnJHWXlEOE5GLUZ1eXpqMUE3RGlsSDhfdzc1SVo3U0lKbmg1cnZJaVZ6U1dTVDZ3R0VPMVdwdklaSEJ0ODUzZkk1YlkwNm9kc0VybGN0dUk2M3VObWQtV1VVZWc2WDdXcW1SMHlpY2ZaVVFGbkNWa05vbWszMnU4Ynk4U3N4UVh0T0M1YnhrdlNhRGM0a1MzcFRXWXBWaXR1ckluWVE2aGQ2eTFBZndYWWdhMG93eDNBZXo4eEZ3SENQUGVobE1MRkZi?oc=5" target="_blank">Association of Oxidative Stress With Biochemical Markers in Diabetic and Non-diabetic Chronic Kidney Disease Patients: A Cross-Sectional Study</a>  <font color="#6f6f6f">Cureus</font>

Non-diabetic Kidney Disease in Type 2 Diabetes: From Kidney Biopsy to Precision Medicine
Cureusgeneral

Non-diabetic Kidney Disease in Type 2 Diabetes: From Kidney Biopsy to Precision Medicine

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxORVdneUI2ajVUSGlKREFyR3U2UnVJcURNZHhEZHFMemFHOWZNU1VwVXU3MkN2ZE5TdkIxdld1WGRRYkF3NmptTlkwdkJtOUlmSVlYZkFab3hPaFlBZUlEdGRxOG16OVlvSkgwU2FYa2lwd2hZa0p3TWplalNXWVRMVGlPcmNiZm53am5WanJ0c0diV0lsX0JGTkhZeDlSSTdlNGZWY2VtWElkakx4amI1R0lxZVlYVkViS2x0UGVzNDNxMUZN?oc=5" target="_blank">Non-diabetic Kidney Disease in Type 2 Diabetes: From Kidney Biopsy to Precision Medicine</a>  <font color="#6f6f6f">Cureus</font>

Severe Nondiabetic Hypoglycemia After Risperidone Initiation in an Adult With Schizophrenia: A Case Report and Systematic Review
Cureusgeneral

Severe Nondiabetic Hypoglycemia After Risperidone Initiation in an Adult With Schizophrenia: A Case Report and Systematic Review

<a href="https://news.google.com/rss/articles/CBMi-gFBVV95cUxPWEtvRWtieEpSeV9ORGgzd05TQ3dORm5tQTR5bTB5YmNmcURaR3cybVR0UkRYY3RkUmZHY3lzbkdzZjI2S2R3eFFjNlpMUkxURHgzOWhEN1FMaS1heHM1Q29IMjQ2RGtjdEFzVEtsN0NRLVY1SUpHUlhad1l1Qk15WWdsaXhyRlI0ZXZSZTRnUUZrMGJ1NFhkMWFiUEdXOEVfRk9POHJzVDhFbW82ZVFydTRRdVJPZmJVb0ZyMjBJUEV2ZlA2RFJoWXgwaWR0cXVGbzNGWEc2YjdNdWJxV0pqQU92UXpBY1RLTkEyZlZ2eUF0dDNTOVctV2F3?oc=5" target="_blank">Severe Nondiabetic Hypoglycemia After Risperidone Initiation in an Adult With Schizophrenia: A Case Report and Systematic Review</a>  <font color="#6f6f6f">Cureus</font>

Evaluation of the accuracy, precision, and agreement of a glucometer compared to the standard laboratory test in diabetic and non-diabetic patients
Naturegeneral

Evaluation of the accuracy, precision, and agreement of a glucometer compared to the standard laboratory test in diabetic and non-diabetic patients

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE96M1haV0NKRTN5SjdkWFhiRkpIcHdrWnlWeFhLZXFDd0RSZGswRzJPWEhxSjZsTjZybTVQRXF1VnhwS0NwMWJYRS10NG5HYXNvSU8zNUxLcWI5YlR3WE1n?oc=5" target="_blank">Evaluation of the accuracy, precision, and agreement of a glucometer compared to the standard laboratory test in diabetic and non-diabetic patients</a>  <font color="#6f6f6f">Nature</font>

Gastrointestinal Effects of GLP-1 Drive Discontinuation for Nondiabetic Adults
Drug Topicsgeneral

Gastrointestinal Effects of GLP-1 Drive Discontinuation for Nondiabetic Adults

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQZ1N6YUZ4V2g3RW9reTlYSFhDU2R1UjIwQWNfQjJLM0p6dmxrcDFzUXJIUDJaTFVhd0JfM01BOWhWMnBJQ3dpTHRPYk43TWRiRXItTmVjQ2RtU3R2SFgxRFlhaUFiYjN6MFNTdGxTb1BwaERaYjNqMzVrcExwanlTRXdSVjk1bUJyTnZqMTliZkhuV0JTVi1rT1M2b0ZxMFhEMHZXVEllcnRleFFjQkhz?oc=5" target="_blank">Gastrointestinal Effects of GLP-1 Drive Discontinuation for Nondiabetic Adults</a>  <font color="#6f6f6f">Drug Topics</font>

Which GLP-1 medication is most effective for weight loss?
UGA Todaygeneral

Which GLP-1 medication is most effective for weight loss?

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTFBRemcxTFR3U0ZoS2xiNTN5b1o4eFVuNVRLMG9PTmFlMjNYZWhIUGFTN21Oc09qYkk5RU1MYnhTSHhyUUs2SVdoVHRFYUlTU0xEMjk0NHI2TFdiQjBpSnB0d2I2bDZ2R0YwVmdkdTY3NHZocDNLVWc?oc=5" target="_blank">Which GLP-1 medication is most effective for weight loss?</a>  <font color="#6f6f6f">UGA Today</font>

Finerenone meets primary endpoint in pivotal Phase III FIND-CKD study in patients with non-diabetic chronic kidney disease
Bayergeneral

Finerenone meets primary endpoint in pivotal Phase III FIND-CKD study in patients with non-diabetic chronic kidney disease

<a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxOWDNHU2x1WVdWSXVsWVZLT0NwYTlsc0hFZ2IwR0ZISHJZaExKajFTR2JZaHV1X3R1UGFZRUtwY0FlckN5SUNkOFRsNWNZM3huZEdsV05MempOT0FYaFN6MmNZMFA3NEk3OWFkMXhlTUFOaFV2MzBkYnh2NG5ST2kxOGpremozMHZoMkJyanNUOTZWWDU3SWNiMy1PX3p2OWNWVkVMZm5yS3ljRjRLY1g0M0I4ZXhzTllacFM4TzdCbDREak5uWjVXTFJGWU9EUzlmSEpkMHMzVFpZWnE0Qnk0cm13em1KRnZ5VEw5Qmhn?oc=5" target="_blank">Finerenone meets primary endpoint in pivotal Phase III FIND-CKD study in patients with non-diabetic chronic kidney disease</a>  <font color="#6f6f6f">Bayer</font>

Kidney Compass: FIND-CKD Extends Finerenone's Benefit to Non-Diabetic CKD
HCPLivegeneral

Kidney Compass: FIND-CKD Extends Finerenone's Benefit to Non-Diabetic CKD

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQR0xDTURsZVByN180STBOcXdGNVhzRW5hRVMxUDE5eERBRGIxYjJLOEJySnpMOWw2dk1WTGdzVV9HeEpiTkUyTlU5d0dwUnhDcWM1ZzZNeGxWcFUyVzdfc2xQQ05uMHBickZFTWFYT0NyYWxJYVYwVFN5d2x2RUVIQ0hrZVdSR2N5dktCTXd5ZS02X1N6LXpSMnZnbWhNZU9KWktr?oc=5" target="_blank">Kidney Compass: FIND-CKD Extends Finerenone's Benefit to Non-Diabetic CKD</a>  <font color="#6f6f6f">HCPLive</font>

Broadening perspectives on hypoglycemia diagnosis in non-diabetic patients
www.elsevier.comgeneral

Broadening perspectives on hypoglycemia diagnosis in non-diabetic patients

<a href="https://news.google.com/rss/articles/CBMiiAJBVV95cUxNdDREbVRySHdJR0Qyel9abnQ5MlYzZlVjUHNpanNOVDU1ZDVpeF9SejJTM3ZkZ2xTX0xxLV9hSHc5Z1hKd1YyR3NWUVJmLWxDdU12S3lMdm8tX3N1SXBTOE1vUDZic3hDWWdkbm01ODdSLXJCLWR4NE5EdENOd1NlOHpOQzhtcjFCSlBUNzNwVFBWRV9ONUlzSi0zTXg2cnZ4a0tPRkJob2YxZ3NFUDZWcnJQMFVDeTlhVUNUWnU1bGxmWkc5Y3p3MjBtaDVxOUhMUTMxdEJhTnU0SG04a241eFJxMHlnUVNXVmJwY3M5b3lyMVl5b1NDMEoyY3FpZUw3a0EtOHhJSHY?oc=5" target="_blank">Broadening perspectives on hypoglycemia diagnosis in non-diabetic patients</a>  <font color="#6f6f6f">www.elsevier.com</font>

Long-Term Cardiovascular Outcomes of Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Obesity: A Systematic Review and Meta-Analysis
Cureusgeneral

Long-Term Cardiovascular Outcomes of Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Obesity: A Systematic Review and Meta-Analysis

<a href="https://news.google.com/rss/articles/CBMiiwJBVV95cUxOVTdXS0hYcWZiUlBTNUJPclZVRHZJS1pqa1pOS2VZWDRfOW10QWlERTVKcG1FeFQyN0FEYldpcFBvRVZUNHo5QkR0U3AwVkUxTFhLZVZvNE1oTDBKNVh6QnhnR2t4R3Z2ejZpTm5BcVE0LVlnWE9jNXBtTHRSZzAwVEtscnI2aDdJZS1Fd01POWsxRURaaS12aVVWa3JoU3oyWmpFTGhJRk1Od3llbmdyczYtQ2g5eDNkemdpdFFBQVpYREdZNVVPY1NPNng1SlBLeFhiQ2RyU1IwU3VOS1hQVDBPWThkRE9sdUFxOGt2ZTdWNUxvSVRPZjhnb3AxNFdlcmhFeGE1OVI2XzQ?oc=5" target="_blank">Long-Term Cardiovascular Outcomes of Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Obesity: A Systematic Review and Meta-Analysis</a>  <font color="#6f6f6f">Cureus</font>

Finerenone Meets Primary End Point in Nondiabetic Chronic Kidney Disease Trial
Pharmacy Timesgeneral

Finerenone Meets Primary End Point in Nondiabetic Chronic Kidney Disease Trial

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOYVVFQkFDVGdqRzVhZ2E4R2NiVVJWUWN0Q2ZmVVpDZ01lVGl3WUs1blpCMExiZTB3Wk1jY1ZHRWpCQzU2NDhTS2c3aWY2dUJRVEprMEJUb0lmNGxJRGxEczMyTWR2d0UzbHl5dWJTejk2WDB0cy1WZ0VoU2xic1RYWURTcHpGQ0d5ZjJRZVk5NUsycDVRakVlQmtDaXBYWXhCWlJZdVV6MXpMRUp4VWplekxfT3g?oc=5" target="_blank">Finerenone Meets Primary End Point in Nondiabetic Chronic Kidney Disease Trial</a>  <font color="#6f6f6f">Pharmacy Times</font>

Clinicopathological profile of diabetic versus non-diabetic patients with MASLD-related hepatocellular carcinoma
Springer Nature Linkgeneral

Clinicopathological profile of diabetic versus non-diabetic patients with MASLD-related hepatocellular carcinoma

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE8xY2UtVUhoRGZmSEh3TVRqZlgta1BqNks3SUJGTWRsZGhWZlA2cXVxVjFtZ3lwX3J5alFvUDV3X0pCbmx6RnRubDhQV2pZeVl2bW9lbGdPZ3UzcENIZUJIeFAzLUJfSDMweG9URw?oc=5" target="_blank">Clinicopathological profile of diabetic versus non-diabetic patients with MASLD-related hepatocellular carcinoma</a>  <font color="#6f6f6f">Springer Nature Link</font>

Periodontal Disease Prevalence Among Diabetic Patients: A Cross-Sectional Study at a Regional Hospital in Uganda
Cureusgeneral

Periodontal Disease Prevalence Among Diabetic Patients: A Cross-Sectional Study at a Regional Hospital in Uganda

<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxNSS1pT3BlNGpSUzNQRUpiYUc2bjVqNVFHN3hYNjI4MHZEWkhES29XdDdCcjZiRGdvUnluRGVfNC1peEFoNVFaMW9kcGI0Sl9zT0wxYjFwaGpBamdhVWszRkFUN3FieU1TTjA3UTZfV3g4Smw1Y2sySUwzZElWRFNaN25sei1GQVB1bXNieWM5clExN0FvMDVOT0JZekdPMWRIX2htMU9PZ2F1V0JkQ1dGMDR4NUF0WF9qa0ZMSVcwRUthdEhDN1dpTEtiQjcwUDJEdHhubG1ZTnZ0eFN6RVVQRjhjckY?oc=5" target="_blank">Periodontal Disease Prevalence Among Diabetic Patients: A Cross-Sectional Study at a Regional Hospital in Uganda</a>  <font color="#6f6f6f">Cureus</font>

"Non-Diabetic Patients on" — Live Google News Trends & Headlines